期刊
NATURE
卷 574, 期 7777, 页码 273-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41586-019-1618-0
关键词
-
资金
- Aplastic Anemia and MDS International Foundation (AAMDSIF)
- Lauri Strauss Leukemia Foundation
- Leukemia and Lymphoma Society Special Fellow Award
- JSPS Overseas Research Fellowships
- Bloodwise Clinician Scientist Fellowship [15030]
- Oglesby Charitable Trust
- NIH/NCI [K99 CA218896]
- ASH Scholar Award
- Cancer Research UK [C5759/A20971]
- CPRIT [RP140800]
- Welch Foundation [H-1889-20150801]
- NIH/NHLBI [R01 HL128239]
- Department of Defense Bone Marrow Failure Research Program [W81XWH-16-1-0059]
- Starr Foundation [I8-A8-075]
- Henry & Marilyn Taub Foundation
- Edward P. Evans Foundation
- Josie Robertson Investigator Program
- Leukemia and Lymphoma Society
- Pershing Square Sohn Cancer Research Alliance
Transcription and pre-mRNA splicing are key steps in the control of gene expression and mutations in genes regulating each of these processes are common in leukaemia(1,2). Despite the frequent overlap of mutations affecting epigenetic regulation and splicing in leukaemia, how these processes influence one another to promote leukaemogenesis is not understood and, to our knowledge, there is no functional evidence that mutations in RNA splicing factors initiate leukaemia. Here, through analyses of transcriptomes from 982 patients with acute myeloid leukaemia, we identified frequent overlap of mutations in IDH2 and SRSF2 that together promote leukaemogenesis through coordinated effects on the epigenome and RNA splicing. Whereas mutations in either IDH2 or SRSF2 imparted distinct splicing changes, co-expression of mutant IDH2 altered the splicing effects of mutant SRSF2 and resulted in more profound splicing changes than either mutation alone. Consistent with this, co-expression of mutant IDH2 and SRSF2 resulted in lethal myelodysplasia with proliferative features in vivo and enhanced self-renewal in a manner not observed with either mutation alone. IDH2 and SRSF2 double-mutant cells exhibited aberrant splicing and reduced expression of INTS3, a member of the integrator complex(3), concordant with increased stalling of RNA polymerase II (RNAPII). Aberrant INTS3 splicing contributed to leukaemogenesis in concert with mutant IDH2 and was dependent on mutant SRSF2 binding to cis elements in INTS3 mRNA and increased DNA methylation of INTS3. These data identify a pathogenic crosstalk between altered epigenetic state and splicing in a subset of leukaemias, provide functional evidence that mutations in splicing factors drive myeloid malignancy development, and identify spliceosomal changes as a mediator of IDH2-mutant leukaemogenesis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据